Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Macro Group Pharmaceuticals (Macro Capital) Co Days Payable?
Macro Group Pharmaceuticals (Macro Capital) CoCAI:MCRO -0.66%38 Days Payable is 108.14 as of Mar. 2026, which is 6% below its 10-year median of 114.53. GuruFocus rates CAI:MCRO with a GF Score™ of 38/100. The stock has 2 warning signs investors should review. Among 1,896 Consumer Packaged Goods companies, Macro Group Pharmaceuticals (Macro Capital) Co ranks better than 88.77% on this metric.
CAI:MCRO's Days Payable is ranked better than 88.77% of 1896
companies
in the Consumer Packaged Goods industry
Industry Median: 44.145
vs CAI:MCRO: 128.46
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macro Group Pharmaceuticals (Macro Capital) Co Days Payable Chart
Macro Group Pharmaceuticals (Macro Capital) Co Annual Data
Trend
Dec20
Dec21
Dec22
Days Payable
0.00
115.87
113.19
Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Macro Group Pharmaceuticals (Macro Capital) Co Days Payable vs Consumer Packaged Goods Industry
Macro Group Pharmaceuticals (Macro Capital) Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a Days Payable of 108.14 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors. This is near median its historical median of 114.53. Over the past decade, Macro Group Pharmaceuticals (Macro Capital) Co's Days Payable has ranged from 113.19 to 128.46. According to the industry distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #213 out of 1896 companies in the Consumer Packaged Goods industry, placing it in the top 11.2%.
Is Macro Group Pharmaceuticals (Macro Capital) Co's Days Payable too high?
Macro Group Pharmaceuticals (Macro Capital) Co's current Days Payable of 108.14 is near median its 10-year median of 114.53. Over the past 10 years, this metric has ranged from a low of 113.19 to a high of 128.46. The Consumer Packaged Goods industry median Days Payable is 44.15. Macro Group Pharmaceuticals (Macro Capital) Co's value of 108.14 is 145% above this industry median. Based on the distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #213 out of 1896 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Macro Group Pharmaceuticals (Macro Capital) Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Macro Group Pharmaceuticals (Macro Capital) Co's Days Payable compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Macro Group Pharmaceuticals (Macro Capital) Co ranks #213 out of 1896 companies for Days Payable. This places Macro Group Pharmaceuticals (Macro Capital) Co in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 44.15. Macro Group Pharmaceuticals (Macro Capital) Co's value of 108.14 is 145% above this benchmark. Historically, Macro Group Pharmaceuticals (Macro Capital) Co's own Days Payable has ranged from 113.19 to 128.46 over the past decade. While the company's 10-year median is 114.53 vs. the industry median of 44.15, Macro Group Pharmaceuticals (Macro Capital) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.15, based on 1,896 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Macro Group Pharmaceuticals (Macro Capital) Co's current Days Payable of 108.14 is 145% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Macro Group Pharmaceuticals (Macro Capital) Co's current Days Payable is 108.14, which is near median its own 10-year median of 114.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macro Group Pharmaceuticals (Macro Capital) Co stock overvalued right now?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a current Days Payable of 108.14. The current Days Payable is 108.14, which is near median its 10-year median of 114.53 and 145% above the Consumer Packaged Goods industry median of 44.15. Macro Group Pharmaceuticals (Macro Capital) Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO), the current Days Payable is 108.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.
38GF Score
Get the complete analysis for CAI:MCRO
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:MCRO has been successfully added to your 
